BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23462605)

  • 1. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.
    Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE
    Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphoproteomics and Biomedical Analytics Identify the c-Myc, EZH2, Sirt1 and CXCR4 Pathways as Potential Blocks to Differentiation Leading to Proliferation and Metastatic Potential in Sinonasal Undifferentiated Carcinoma (SNUC) and Provide Therapeutic Options: A Case Study.
    Brown RE; Roy S; McGuire MF
    Ann Clin Lab Sci; 2018 Sep; 48(5):659-664. PubMed ID: 30373873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
    Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A
    Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinonasal undifferentiated carcinoma metastatic to the skin.
    Sohsman M; Yang HM; Cassarino DS
    J Cutan Pathol; 2010 Dec; 37(12):1241-4. PubMed ID: 19682175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative chemoradiation for sinonasal undifferentiated carcinoma of the anterior nasal cavity resected through a lateral nasal flap approach.
    Surapaneni B; Kadakia S; Slupchynskyj O; Iacob C; Holliday R
    Am J Otolaryngol; 2016; 37(2):120-4. PubMed ID: 26954865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
    Kuo P; Manes RP; Schwam ZG; Judson BL
    Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
    Ejaz A; Wenig BM
    Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).
    Wadsworth B; Bumpous JM; Martin AW; Nowacki MR; Jenson AB; Farghaly H
    Head Neck Pathol; 2011 Dec; 5(4):349-54. PubMed ID: 21805120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma.
    Revenaugh PC; Seth R; Pavlovich JB; Knott PD; Batra PS
    Am J Otolaryngol; 2011; 32(6):464-9. PubMed ID: 21041001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers.
    Bell D; Hanna EY
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):285-96. PubMed ID: 23477516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
    van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
    Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
    Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
    Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
    Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinonasal Undifferentiated Carcinoma.
    Abdelmeguid AS; Bell D; Hanna EY
    Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic management of sinonasal undifferentiated carcinoma.
    Tyler MA; Holmes B; Patel ZM
    Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Induction Therapy for Sinonasal Cancers.
    Kong KA; Thorp BD; Sheth SH
    Curr Treat Options Oncol; 2023 Mar; 24(3):162-169. PubMed ID: 36696082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting
    Robinson H; Green M; Radkar G; Ready N; Strickler J
    Cancer Invest; 2021 Mar; 39(3):235-239. PubMed ID: 33538211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
    Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
    J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
    Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
    Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.